| NSCIF Stock | | | USD 0.10 -0.01 -9.09% |
This math operators tool runs Price Series Multiplication operator and companion studies for Nanalysis Scientific and SideChannel. It emphasizes relative price relationships between Nanalysis Scientific and SideChannel while keeping volatility, risk, and performance context in view.
Most technical analysis of Nanalysis Scientific help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Nanalysis from various momentum indicators to cycle indicators. When you analyze Nanalysis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Nanalysis Scientific Corp., develops, manufactures, and sells compact nuclear magnetic resonance spectrometers and magnetic resonance imaging equipment for the pharmaceutical, biotech, chemical, security, food, materials, and education industries. It sells its products directly, as well as through a network of distributors worldwide. NANALYSIS SCIENTIFIC operates under Scientific Technical Instruments classification in the United States and is traded on OTC Exchange. It employs 107 people. Liquidity and trading activity can influence how quickly new information is reflected in Nanalysis Scientific's price. Lower trading activity may introduce occasional variability in execution conditions. Nanalysis Scientific has a market cap of 47.47 M, ROE of -19.7%.
Methodology
Unless otherwise specified, financial data for Nanalysis Scientific Corp is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Nanalysis (USA Stocks:NSCIF) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: The data underlying this report is sourced from public filings and market reference sources, including filings and releases published by U.S. Securities and Exchange Commission (SEC) via EDGAR. Some updates may be delayed based on publication cadence. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Nanalysis Scientific Corp may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
This content is curated and reviewed by:
Michael Smolkin - Member of Macroaxis Board of Directors
Tracking Nanalysis Scientific inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.